4/23/2024  9:59:56 PM Chg. +0.41 Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
149.52USD +0.27% 411,154
Turnover: 61.51 mill.
-Bid Size: - -Ask Size: - 360.26 bill.USD 3.14% 10.78

Business description

Johnson & Johnson and its subsidiaries (the "Company") have employees worldwide engaged in the research and development, manufacture and sale of a broad range of products in the health care field. Johnson & Johnson is a holding company, which has more than 250 operating companies conducting business in virtually all countries of the world. The Company’s primary focus is products related to human health and well-being. Johnson & Johnson was incorporated in the State of New Jersey in 1887.

Management board & Supervisory board

Joaquin Duato
Management board
Joseph Wolk, Ashley McEvoy, Dr. Peter M. Fasolo, Dr. William N. Hait, James Swanson, Jennifer Taubert, Kathryn E. Wengel, Michael H. Ullmann, Vanessa Broadhurst, John C. Reed, M.D., Ph.D., Liz Forminard
Supervisory board
Alex Gorsky, A. Eugene Washington, M.D., Anne M. Mulcahy, D. Scott Davis, Darius Adamczyk, Dr. Jennifer A. Doudna, Dr. Mary Beckerle, Dr. Nadja West, Hubert Joly, Ian E. L. Davis, Joaquin Duato, Marillyn A. Hewson, Mark A. Weinberger, Mark B. McClellan, Paula A. Johnson, M.D.

Company data

Name: Johnson & Johnson
Address: One Johnson & Johnson Plaza,,New Brunswick, New Jersey 08933, USA
Phone: +1-732-524-0400
Fax: -
E-mail: -
Internet: www.jnj.com
Industry: Healthcare
Sector: Pharmaceutical Industry
Sub sector: Pharmaceuticals
End of financial year: 12/31
Free Float: 77.97%
IPO date: 9/24/1944

Investor relations

Name: -
IR phone: +1-800-950-5089
IR Fax: -
IR e-mail: investor-relations@its.jnj.com